{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:41:23Z","timestamp":1784194883313,"version":"3.55.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,4,1]]},"abstract":"<jats:sec><jats:title>Objectives.<\/jats:title><jats:p>To estimate the cost and health benefits of implementing a risk factor-based prevention strategy for early-onset neonatal group B streptococcal (GBS) disease, using baseline assumptions and costs from a health maintenance organization. With the risk factor-based strategy, intrapartum antibiotics (IPAs) would be provided to women with fever, prolonged rupture of membranes, or preterm labor. A second objective was to determine the impact of an increased length of stay for well term infants with mothers who received IPAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We used decision analysis to compare the costs and benefits of the prevention strategy with usual obstetric practice for a cohort of 100\u2009000 women and their newborn infants. We derived baseline values from a previous study based on chart review and automated cost data from a health maintenance organization in Northern California. In sensitivity analyses, we varied baseline assumptions, including additional costs for observing well term infants who received IPAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>If adherence to guidelines were 100%, 17% of mothers would receive IPAs at a cost of $490\u2009000; $1.6 million would be saved by preventing 66 GBS cases (64% reduction). The net savings would be $1.1 million and 61 life-years. The net cost is sensitive to the cost of caring for well infants who received IPAs. If each term infant of a mother who received IPAs had 1 more day of observation than other term infants, there would be a net cost of $8.1 million; the cost per GBS case prevented would be $120\u2009000 and the cost per life-year saved would be $130\u2009000.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>Implementation in a health maintenance organization of a risk factor-based strategy to prevent neonatal GBS disease can prevent substantial disease and be cost saving. However, if the length of hospital stay were extended among well term infants whose mothers received IPAs, the strategy would be relatively costly compared with other medical interventions.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.103.4.703","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"703-710","source":"Crossref","is-referenced-by-count":36,"title":["Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics"],"prefix":"10.1542","volume":"103","author":[{"given":"Janet C.","family":"Mohle-Boetani","sequence":"first","affiliation":[{"name":"From the California Department of Health Services, Berkeley; and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Lieu","sequence":"additional","affiliation":[{"name":"Division of Research, the Permanente Medical Group, Oakland, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Thomas","family":"Ray","sequence":"additional","affiliation":[{"name":"Division of Research, the Permanente Medical Group, Oakland, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Escobar","sequence":"additional","affiliation":[{"name":"Division of Research, the Permanente Medical Group, Oakland, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Neonatal GBS Prevention Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1999,4,1]]},"reference":[{"key":"2021121009340957500_B1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198606263142603","article-title":"Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.","volume":"314","author":"Boyer","year":"1986","journal-title":"N Engl J Med."},{"key":"2021121009340957500_B2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1542\/peds.90.5.775","article-title":"Guidelines for prevention of group B streptococcal infection by chemoprophylaxis.","volume":"90","author":"American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn","year":"1992","journal-title":"Pediatrics."},{"key":"2021121009340957500_B3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00006454-199508000-00003","article-title":"Barriers to prevention of perinatal group B streptococcal disease.","volume":"14","author":"Jafari","year":"1995","journal-title":"Pediatr Infect Dis J."},{"key":"2021121009340957500_B4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0029-7844(96)00372-9","article-title":"Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis.","volume":"89","author":"Whitney","year":"1997","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00006250-199404000-00026","article-title":"A survey of practices in infectious diseases by obstetrician-gynecologists.","volume":"83","author":"Gibbs","year":"1994","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B6","first-page":"1","article-title":"Survey shows continued confusion over management of GBS in pregnancy.","volume":"38","author":"American College of Obstetricians and Gynecologists","year":"1994","journal-title":"ACOG Newslett."},{"key":"2021121009340957500_B7","first-page":"2","article-title":"Group B streptococcal infection in pregnancy: ACOG's recommendations.","volume":"37","author":"Hankins","year":"1993","journal-title":"ACOG Newslett."},{"key":"2021121009340957500_B8"},{"key":"2021121009340957500_B9"},{"key":"2021121009340957500_B10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.99.3.489","article-title":"Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection.","volume":"99","author":"American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn","year":"1997","journal-title":"Pediatrics."},{"key":"2021121009340957500_B11"},{"key":"2021121009340957500_B12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1542\/peds.91.1.148","article-title":"Group B streptococcal infections: an obstetrical viewpoint.","volume":"91","author":"Larson","year":"1993","journal-title":"Pediatrics."},{"key":"2021121009340957500_B13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0002-9378(11)90654-1","article-title":"Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization.","volume":"163","author":"Strickland","year":"1990","journal-title":"Am J Obstet Gynecol."},{"key":"2021121009340957500_B14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jama.1993.03510120064032","article-title":"Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis.","volume":"270","author":"Mohle-Boetani","year":"1993","journal-title":"JAMA."},{"key":"2021121009340957500_B15","first-page":"367","article-title":"An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection.","volume":"83","author":"Yancey","year":"1994","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00006250-199404000-00001","article-title":"Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.","volume":"83","author":"Rouse","year":"1994","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0029-7844(97)00278-0","article-title":"The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease.","volume":"90","author":"Fargason","year":"1997","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0029-7844(98)00147-1","article-title":"Perinatal group B streptococcal infection in a managed care population.","volume":"92","author":"Lieu","year":"1998","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B19"},{"key":"2021121009340957500_B20"},{"key":"2021121009340957500_B21"},{"key":"2021121009340957500_B22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9378(66)90438-8","article-title":"Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy.","volume":"96","author":"Bray","year":"1966","journal-title":"Am J Obstet Gynecol."},{"key":"2021121009340957500_B23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1539-6924.1995.tb00330.x","article-title":"Five hundred life-saving interventions and their cost-effectiveness.","volume":"15","author":"Tengs","year":"1995","journal-title":"Risk Anal."},{"key":"2021121009340957500_B24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archpedi.1996.02170330028005","article-title":"Impact of maternal group B streptococcal screening on pediatric management in full-term newborns.","volume":"150","author":"Peralta-Carcelen","year":"1996","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2021121009340957500_B25","first-page":"487","article-title":"Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage.","volume":"82","author":"McDuffie","year":"1993","journal-title":"Obstet Gynecol."},{"key":"2021121009340957500_B26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00006454-199410000-00003","article-title":"Early discontinuation of antibiotic treatment in newborns admitted to rule out sepsis: a decision rule.","volume":"13","author":"Escobar","year":"1994","journal-title":"Pediatr Infect Dis J."},{"key":"2021121009340957500_B27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00019514-199705040-00003","article-title":"Rapid retrieval of neonatal outcomes data: the Kaiser Permanente Neonatal Minimum Data Set.","volume":"5","author":"Escobar","year":"1997","journal-title":"Qual Manage Health Care."},{"key":"2021121009340957500_B28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9378(87)80336-8","article-title":"Reduction of group B streptococcal maternal and neonatal infection in preterm pregnancies with premature rupture of membranes through a rapid identification test.","volume":"157","author":"Morales","year":"1987","journal-title":"Am J Obstet Gynecol."},{"key":"2021121009340957500_B29"},{"key":"2021121009340957500_B30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.1997.03550120049032","article-title":"Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes.","volume":"278","author":"Mercer","year":"1997","journal-title":"JAMA."},{"key":"2021121009340957500_B31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0002-9378(86)90731-3","article-title":"An obstetric approach to the prevention of early-onset group B beta-hemolytic streptococcal sepsis.","volume":"154","author":"Minkoff","year":"1986","journal-title":"Am J Obstet Gynecol."},{"key":"2021121009340957500_B32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(88)80002-4","article-title":"Ampicillin propylaxis in preterm premature rupture of the membranes: a prospective randomized study.","volume":"159","author":"Amon","year":"1988","journal-title":"Am J Obstet Gynecol."},{"key":"2021121009340957500_B33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/infdis\/148.5.795","article-title":"Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale.","volume":"148","author":"Boyer","year":"1983","journal-title":"J Infect Dis."},{"key":"2021121009340957500_B34","first-page":"84","article-title":"Guideline for preventing perinatal GBS infection.","volume":"7","author":"Mead","year":"1996","journal-title":"Contemp Obstet Gynecol."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/4\/703\/842328\/703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/4\/703\/842328\/703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:32:46Z","timestamp":1682746366000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/103\/4\/703\/65951\/Preventing-Neonatal-Group-B-Streptococcal-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1999,4,1]]},"published-print":{"date-parts":[[1999,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.103.4.703","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4,1]]}}}